Archives
-
E-64 Workflows for Cysteine Protease Assays
2026-10-01
E-64 combines irreversible active-site chemistry with practical workflows for enzyme kinetics, cathepsin inhibition, lysosomal studies, and cancer research. This guide shows how to use its broad cysteine protease activity while avoiding overinterpretation in cathepsin S and lymphoma experiments.
-
Y-27632 Dihydrochloride: ROCK Inhibitor Workflows
2026-10-01
Build more reproducible dissociation, recovery, cytoskeletal, and invasion assays with a selective ROCK inhibitor. This guide connects practical Y-27632 dihydrochloride handling to a 2025 human myogenic progenitor study, while separating evidence-backed findings from workflow starting points.
-
Sumatriptan Succinate: Assay Workflows
2026-09-30
Build more informative migraine, receptor, inflammation, and metabolism assays with Sumatriptan Succinate. This workflow combines receptor-proximal readouts with HPLC-MS metabolite mapping to distinguish pharmacology from exposure and biotransformation artifacts.
-
IBDV VP3 Disrupts IRF7 to Promote Viral Replication
2026-09-30
The reference study identifies a post-translational immune-evasion mechanism in which infectious bursal disease virus (IBDV) VP3 interferes with IRF7 abundance and proteasome-dependent turnover, weakening type I interferon signaling. Its infection, genetic perturbation, pathway-inhibitor, and protein-interaction experiments position VP3 as a key facilitator of viral replication and provide a framework for studying virus-driven manipulation of host protein stability.
-
TMRE Mitochondrial Membrane Potential Assay Kit
2026-09-29
The TMRE mitochondrial membrane potential assay kit converts ΔΨm into a quantitative red-fluorescence readout for apoptosis and mitochondrial physiology. This guide explains how to interpret TMRE during sodium-driven energy failure, distinguish depolarization from downstream cell death, and design stronger validation workflows.
-
Griseofulvin Workflows for Microtubule Research
2026-09-29
Use Griseofulvin as a practical microtubule associated inhibitor for linking fungal growth phenotypes to cell-division mechanism. This workflow combines solvent control, time-course imaging, dose optimization, and reference-inspired flow cytometry to distinguish microtubule effects from nonspecific toxicity.
-
JHU-083: Workflow for Glutaminase Research
2026-09-28
JHU-083 is a 6-diazo-5-oxo-L-norleucine precursor designed for selective glutaminase pathway studies in cerebral immune-cell and neurological disease models. This guide turns its metabolic mechanism into a practical workflow, while showing how redox and glutathione assays can add context without overextending findings from liver toxicology.
-
CD40–STING–TRAF2 Signaling in ESCC TLS
2026-09-28
In treatment-naïve esophageal squamous cell carcinoma, tertiary lymphoid structures were associated with favorable survival and an IRF4-positive B-cell signature. The study links CD40–STING competition for TRAF2 to STING modification, non-canonical NF-κB signaling, and B-cell activation, while leaving important questions about causality and clinical application open.
-
HBTU for Enzyme-Responsive Peptide Workflows
2026-09-27
HBTU can support rapid, carefully monitored peptide bond formation when building enzyme-responsive peptide candidates, including zwitterionic designs inspired by recent cancer-selectivity research. This guide separates the study’s biological findings from practical coupling recommendations and provides a small-scale workflow, optimization controls, and troubleshooting steps.
-
Indometacin Sodium for Inflammation Assays
2026-09-26
Indometacin Sodium offers a practical way to probe COX-dependent prostaglandin biology while also supporting carefully controlled studies of stromal proliferation and oligodendrocyte differentiation. This guide turns its reported concentration ranges into a reproducible workflow—and separates mechanistic assay evidence from the unrelated clinical findings of the RISOTTO trial.
-
PYR-41 for E1-Dependent IRF7 Research
2026-09-25
Use PYR-41 to test whether E1-dependent ubiquitination contributes to IRF7 protein turnover and antiviral signaling—not as a stand-alone antiviral treatment. This workflow pairs dose and viability controls with protein, transcript, and ubiquitination readouts to distinguish pathway effects from compound-related toxicity or off-target activity.
-
Camostat Mesilate: Practical Research Workflows
2026-09-25
Camostat Mesilate supports experiments on airway epithelial sodium channel function and plasmin–TGF-β signaling, with distinct workflows for airway and fibrosis models. This guide covers formulation, assay design, troubleshooting, and how to interpret its relationship to structure-guided antiviral research without conflating different mechanisms.
-
Macrophage EV–miR-660 Drives Breast Cancer Metastasis
2026-09-24
This study links tumor-associated macrophage extracellular vesicles to breast cancer progression, showing that transferred miR-660 reduces KLHL21 function and promotes IKKβ/NF-κB p65 signaling, invasion, and metastasis-related outcomes in experimental models. Its value is a mechanistic account of immune-cell-to-tumor-cell communication, while clinical relevance and therapeutic implications remain to be established.
-
Naloxone hydrochloride: beyond receptor blockade
2026-09-24
Naloxone hydrochloride is best understood not only as an opioid receptor antagonist, but also as a tool for testing how endogenous opioid tone shapes withdrawal-related behavior. We connect CCK-8 research in morphine-withdrawal rats to practical study design, highlight where naloxone can—and cannot—support mechanistic inference, and outline key translational limits.
-
E-64: From Protease Mechanism to Translation
2026-09-23
Cathepsin S can shape antigen processing and immune-cell interactions in lymphoma, but translating that biology into a causal experiment requires careful control of inhibitor selectivity and context. This article positions E-64 as a potent, irreversible cysteine protease tool for testing protease dependence—not as a selective substitute for CTSS genetics—and offers a practical framework for stronger translational studies.